LEAP THERAPEUTICS INC's ticker is LPTX and the CUSIP is 52187K101. A total of 43 filers reported holding LEAP THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $51,997 | -8.7% | 152,931 | +20.8% | 0.00% | – |
| Q4 2022 | $56,952 | -48.7% | 126,561 | 0.0% | 0.00% | – |
| Q3 2022 | $111,000 | -13.3% | 126,561 | +13.9% | 0.00% | – |
| Q2 2022 | $128,000 | -34.0% | 111,122 | 0.0% | 0.00% | – |
| Q1 2022 | $194,000 | -46.1% | 111,122 | 0.0% | 0.00% | – |
| Q4 2021 | $360,000 | +21.2% | 111,122 | +50.3% | 0.00% | – |
| Q3 2021 | $297,000 | +112.1% | 73,951 | -13.1% | 0.00% | – |
| Q2 2021 | $140,000 | -13.6% | 85,064 | 0.0% | 0.00% | – |
| Q1 2021 | $162,000 | -11.5% | 85,064 | +4.7% | 0.00% | – |
| Q4 2020 | $183,000 | +46.4% | 81,266 | +28.2% | 0.00% | – |
| Q3 2020 | $125,000 | +28.9% | 63,378 | +36.7% | 0.00% | – |
| Q2 2020 | $97,000 | +169.4% | 46,354 | +103.6% | 0.00% | – |
| Q1 2020 | $36,000 | +44.0% | 22,763 | 0.0% | 0.00% | – |
| Q4 2019 | $25,000 | -7.4% | 22,763 | 0.0% | 0.00% | – |
| Q3 2019 | $27,000 | – | 22,763 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Asymmetry Capital Management, L.P. | 900,733 | $1,883,000 | 1.44% |
| Sio Capital Management, LLC | 1,501,998 | $3,139,000 | 0.92% |
| CVI Holdings, LLC | 704,900 | $1,473,000 | 0.55% |
| Perceptive Advisors | 8,476,496 | $17,466,000 | 0.28% |
| Artal Group S.A. | 2,974,000 | $6,216,000 | 0.17% |
| SPHERA FUNDS MANAGEMENT LTD. | 880,000 | $1,839,000 | 0.17% |
| DAFNA Capital Management LLC | 275,000 | $575,000 | 0.17% |
| J. Goldman & Co LP | 1,018,285 | $2,128,000 | 0.13% |
| MYDA Advisors LLC | 100,000 | $209,000 | 0.13% |
| 683 Capital Management, LLC | 526,466 | $1,100,000 | 0.09% |